相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients
Alejandro Vallejo et al.
AIDS (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
HIV-1 DNA Is Detected in Bone Marrow Populations Containing CD4+ T Cells but Is not Found in Purified CD34+ Hematopoietic Progenitor Cells in Most Patients on Antiretroviral Therapy
Christine M. Durand et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
A quantitative basis for antiretroviral therapy for HIV-1 infection
Benjamin L. Jilek et al.
NATURE MEDICINE (2012)
Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency
Matthew J. Pace et al.
PLOS PATHOGENS (2012)
Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection
Teresa H. Evering et al.
PLOS PATHOGENS (2012)
Inhibitors of Histone Deacetylases CORRELATION BETWEEN ISOFORM SPECIFICITY AND REACTIVATION OF HIV TYPE 1 (HIV- 1) FROM LATENTLY INFECTED CELLS
Kelly Huber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
Sifei Xing et al.
JOURNAL OF VIROLOGY (2011)
Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+T cells
Suha Saleh et al.
RETROVIROLOGY (2011)
Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+T Cells
Alberto Bosque et al.
PLOS PATHOGENS (2011)
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
D. McMahon et al.
CLINICAL INFECTIOUS DISEASES (2010)
Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
Aylin Yilmaz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
No Evidence for Decay of the Latent Reservoir in HIV-1-Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy
Rajesh T. Gandhi et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction
Mudit Tyagi et al.
JOURNAL OF VIROLOGY (2010)
Combinatorial Latency Reactivation for HIV-1 Subtypes and Variants
John C. Burnett et al.
JOURNAL OF VIROLOGY (2010)
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs
Christoph C. Carter et al.
NATURE MEDICINE (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton
Paul U. Cameron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Rajesh T. Gandhi et al.
PLOS MEDICINE (2010)
Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma
Leonard C. Edelstein et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Nancie M. Archin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Alberto Bosque et al.
BLOOD (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4+ T Cells
Dimitrios N. Vatakis et al.
JOURNAL OF VIROLOGY (2009)
A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
Kara S. Keedy et al.
JOURNAL OF VIROLOGY (2009)
Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
Stephen A. Migueles et al.
JOURNAL OF VIROLOGY (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Nathalie Sagot-Lerolle et al.
AIDS (2008)
HIV-1 viral genes and mitochondrial apoptosis
Devon J. Shedlock et al.
APOPTOSIS (2008)
Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
Stephen A. Migueles et al.
IMMUNITY (2008)
An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency
Alessandra Marini et al.
JOURNAL OF IMMUNOLOGY (2008)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HIV rebounds from latently infected cells, rather than from continuing low-level replication
Beda Joos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration
Luis M. Agosto et al.
VIROLOGY (2007)
Regulation of HIV-1 latency by T-cell activation
Samuel A. Williams et al.
CYTOKINE (2007)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+T-lymphocytes
Gautam K. Sahu et al.
VIROLOGY (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells
Kara G. Lassen et al.
PLOS PATHOGENS (2006)
The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest
K Sakai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli
WJ Swiggard et al.
JOURNAL OF VIROLOGY (2005)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine
DV Havlir et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Genotypic analysis of HIV-1 drug resistance at the limit of detection: Virus production without evolution in treated adults with undetectable HIV loads
TL Kieffer et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis
JM Brenchley et al.
JOURNAL OF VIROLOGY (2004)
The multifactorial nature of HIV-1 latency
K Lassen et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Resting CD4+ T cells from human immunodeficiency virus type I (HIV-1)-infected individuals carry integrated HIV-1 Genomes within actively transcribed host genes
YF Han et al.
JOURNAL OF VIROLOGY (2004)
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression
L Ylisastigui et al.
AIDS (2004)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Molecular characterization, reactivation, and depletion of latent HIV
DG Brooks et al.
IMMUNITY (2003)
Regulation of quiescence in lymphocytes
I Yusuf et al.
TRENDS IN IMMUNOLOGY (2003)
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo
M Hermankova et al.
JOURNAL OF VIROLOGY (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy
LM Frenkel et al.
JOURNAL OF VIROLOGY (2003)
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV:: Intrinsic stability predicts lifelong persistence
MC Strain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals
TW Chun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy
J Kulkosky et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection
TC Pierson et al.
JOURNAL OF VIROLOGY (2002)
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination
M Markowitz et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
HIV-1 integration in the human genome favors active genes and local hotspots
ARW Schröder et al.
CELL (2002)
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
HJ Stellbrink et al.
AIDS (2002)
Death of CD4+ T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis
DL Bolton et al.
JOURNAL OF VIROLOGY (2002)
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion
RME Van Praag et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Generation of HIV latency during thymopoiesis
DG Brooks et al.
NATURE MEDICINE (2001)
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy
LQ Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
T Pierson et al.
JOURNAL OF VIROLOGY (2000)
分享论文
